Cracking Down on Kratom: FDA Investigation, Enforcement, Seizure, and Recall of Products Reported to Contain Kratom - fdli.org
FDA is intensifying investigations and enforcement actions against dietary supplements containing kratom, leading to potential product seizures and recalls.
Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on August 9, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. All dietary supplement manufacturers and distributors that sell products containing kratom. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediate action is recommended as enforcement is already underway.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Increased FDA scrutiny and enforcement actions regarding kratom-containing products, including potential seizures and recalls.
Who it affects
All dietary supplement manufacturers and distributors that sell products containing kratom.
What you must do
Review product formulations and labeling for compliance with FDA regulations regarding kratom.
Deadline
Immediate action is recommended as enforcement is already underway.
Never miss a change like this again
Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trial